Company: BNBX
Filing Date: 2025-11-04
Form Type: 424B5
Source: 0001104659-25-105958
Chunk: 1

Company: BNB PLUS CORP.
Filing Date: 2025-11-04
Form: 424B5
Chunk 1
---
3 as of October 31, 2025, is equal to
$8,157,932. During the 12 calendar months prior to and including the date of this prospectus supplement, we have not sold any securities
pursuant to General Instruction I.B.6 of Form S-3.

Sales of our common stock, if any, under this
prospectus supplement and the accompanying prospectus will be made in sales deemed to be an “at the market offering” as defined
in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended (the “Securities Act”). If we and Lucid
agree on any method of distribution other than sales of our shares of common stock on or through Nasdaq or another existing trading market
in the United States at market prices, we will file a further prospectus supplement providing all information about such offering as required
by Rule 424(b) under the Securities Act. Lucid will act as a sales agent and will use commercially reasonable efforts to sell on our behalf all of the shares of common stock requested to be sold by us, consistent with its normal trading and sales practices, on mutually agreed terms between Lucid and us. There is no arrangement for funds to be received in any escrow, trust or similar arrangement.

Lucid will be entitled to compensation at a fixed
commission rate of 3.0% of the gross sales price of the common stock issued and sold by the Company through Lucid. See “Plan of
Distribution” for additional information regarding compensation to be paid to Lucid. In connection with the sale of the common stock
on our behalf, Lucid will be deemed to be an “underwriter” within the meaning of the Securities Act and the compensation of
Lucid will be deemed to be underwriting commissions or discounts. We have also agreed to provide indemnification and contribution to Lucid
with respect to certain liabilities, including liabilities under the Securities Act and the Securities Exchange Act of 1934, as amended
(the “Exchange Act”).

Investing in our securities involves a high degree of risk. You should review carefully the risks and uncertainties described under the heading “Risk Factors” on page S-15 of this prospectus supplement, page 3 of the accompanying prospectus and under similar headings in the other documents that are incorporated by reference in this prospectus supplement and the accompanying prospectus before purchasing any of the securities offered by this prospectus supplement.

Neither the Securities and Exchange Commission